Prevail Therapeutics Inc (PRVL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | PRVL | SUPN | TSHA | ||
| Company | Prevail Therapeutics Inc | Supernus Pharm | Taysha Gene Therapies Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 23.05 | 30.28 | 2.14 | ||
| High | 23.13 | 30.83 | 2.20 | ||
| Low | 22.97 | 29.99 | 2.12 | ||
| Last | 23.00 | 30.00 | 2.18 | ||
| Change | -0.02 | -0.25 | +0.04 | ||
| % Change | -0.09% | -0.83% | +1.87% | ||
| Volume | 2,619,900 | 794,945 | 953,771 | ||
| 20-Day Average Volume | 721,915 | 543,252 | 3,633,269 | ||
| Previous Close | 23.02 | 30.25 | 2.14 | ||
| Industry | Medical - Generic Drugs | Medical - Generic Drugs | Medical - Generic Drugs | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 23.05 | 27.58 | 2.28 | ||
| 20-Day Raw Stochastic | 40.00% | 81.65% | 30.30% | ||
| 20-Day Relative Strength | 81.56% | 64.18% | 41.21% | ||
| Weighted Alpha | -11.96 | +1.95 | -2.42 | ||
| Today's Opinion | 72% Buy | 24% Buy | 40% Sell | ||
| Previous Opinion | 72% Buy | 8% Buy | 40% Sell | ||
| Last Month's Opinion | 24% Buy | 72% Sell | 56% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -0.13% since 01/13/21 | +4.42% since 07/15/24 | -10.66% since 07/15/24 | ||
| Low | 22.85 on 01/15/21 | 28.44 on 07/18/24 | 2.12 on 07/22/24 | ||
| High | 23.17 on 01/14/21 | 31.00 on 07/19/24 | 2.51 on 07/16/24 | ||
| 1-Month | |||||
| %Chg | -0.39% since 12/21/20 | +10.95% since 06/21/24 | -26.35% since 06/21/24 | ||
| Low | 22.80 on 01/04/21 | 25.55 on 07/03/24 | 1.83 on 06/26/24 | ||
| High | 23.30 on 01/13/21 | 31.00 on 07/19/24 | 2.98 on 06/24/24 | ||
| 3-Month | |||||
| %Chg | +130.00% since 10/21/20 | +0.98% since 04/22/24 | -11.38% since 04/22/24 | ||
| Low | 9.21 on 10/30/20 | 25.53 on 06/14/24 | 1.83 on 06/26/24 | ||
| High | 23.35 on 12/17/20 | 32.87 on 05/09/24 | 4.32 on 06/13/24 | ||
| 6-Month | |||||
| %Chg | +47.25% since 07/21/20 | +5.60% since 01/22/24 | +46.31% since 01/22/24 | ||
| Low | 9.21 on 10/30/20 | 25.53 on 06/14/24 | 1.41 on 02/14/24 | ||
| High | 23.35 on 12/17/20 | 35.44 on 03/21/24 | 4.32 on 06/13/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 787,658 | 1,662,963 | 400,219 | ||
| Shares Outstanding, K | 34,246 | 54,974 | 187,018 | ||
| Annual Sales | 0 | 607,520,000 | 15,450,000 | ||
| Annual Net Income | -63,190,000 | 1,320,000 | -111,570,000 | ||
| Last Quarter Sales | N/A | 143,640,000 | 3,410,000 | ||
| Last Quarter Net Income | N/A | 120,000 | -24,060,000 | ||
| 60-Month Beta | 1.59 | 0.90 | 0.41 | ||
| Per-Share Information | |||||
| Most Recent Earnings | N/A | 0.00 on 05/08/24 | -0.10 on 05/14/24 | ||
| Latest Earnings Date | 11/17/20 | 08/13/24 | 08/12/24 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||